Evaluation of Clinical Outcomes Following Implantation of a Sub-2mm Hydrophilic MICS Intraocular Lens
- First Posted Date
- 2012-06-11
- Last Posted Date
- 2019-11-14
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 103
- Registration Number
- NCT01615861
- Locations
- 🇫🇷
Bausch & Lomb, Labege, France
Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
- First Posted Date
- 2012-05-04
- Last Posted Date
- 2020-09-03
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 360
- Registration Number
- NCT01591655
- Locations
- 🇺🇸
Bausch & Lomb, Incorporated, Rochester, New York, United States
Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
- First Posted Date
- 2012-05-03
- Last Posted Date
- 2020-09-03
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 369
- Registration Number
- NCT01591161
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States
A Study to Evaluate the Product Feasibility of Two New Silicone Hydrogel Contact Lenses
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-04-24
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 216
- Registration Number
- NCT01583868
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States
Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis
- First Posted Date
- 2012-04-16
- Last Posted Date
- 2020-10-05
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 606
- Registration Number
- NCT01578278
- Locations
- 🇺🇸
ISTA Pharmaceuticals, Inc., Irvine, California, United States
Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-04-09
- Last Posted Date
- 2021-01-08
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 131
- Registration Number
- NCT01573572
- Locations
- 🇺🇸
Wolfe Eye Clinic, Marshalltown, Iowa, United States
🇺🇸Valley Retina Institute, Harlingen, Texas, United States
🇺🇸Marietta Eye Clinic, Murrieta, California, United States
A Study to Evaluate the Product Performance of a Low Add MultiFocal Soft Contact Lens
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-02-27
- Last Posted Date
- 2020-09-30
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 126
- Registration Number
- NCT01539694
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States
A Study to Evaluate the Feasibility of a High Add Multi Focal Contact Lens
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-01-26
- Last Posted Date
- 2020-09-30
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 126
- Registration Number
- NCT01518868
- Locations
- 🇺🇸
Bausch & Lomb, Incorporated, Rochester, New York, United States
Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-11-21
- Last Posted Date
- 2019-06-11
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 107
- Registration Number
- NCT01475643
- Locations
- 🇺🇸
Bausch & Lomb Inc, Rochester, New York, United States
A Study to Evaluate the Safety and Efficacy of a New Silicone Hydrogel Contact Lens Design
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-10-10
- Last Posted Date
- 2015-02-18
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 166
- Registration Number
- NCT01449526
© Copyright 2024. All Rights Reserved by MedPath